Miquel Garcia
Bellaterra, CT 08193, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
AAV-mediated FGF21 gene therapy promotes health span extension by whole-body tissue-specific adaptations.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 11, 2025
Nuclear hormone-sensitive lipase regulates adipose tissue mass and adipocyte metabolism.
Journal: Cell metabolism
Published: March 18, 2025
Optimizing RT-qPCR for sex-specific analysis of iron-induced retinal gene expression.
Journal: Experimental eye research
Published: February 03, 2025
Reversion of metabolic dysfunction-associated steatohepatitis by skeletal muscle-directed FGF21 gene therapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 01, 2024
Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapy.
Journal: Molecular metabolism
Published: July 31, 2023
AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity.
Journal: Molecular therapy. Methods & clinical development
Published: July 07, 2021
BMP7 overexpression in adipose tissue induces white adipogenesis and improves insulin sensitivity in ob/ob mice.
Journal: International journal of obesity (2005)
Published: March 10, 2020
FGF21 gene therapy as treatment for obesity and insulin resistance.
Journal: EMBO molecular medicine
Published: July 11, 2018
ALOX5AP Overexpression in Adipose Tissue Leads to LXA4 Production and Protection Against Diet-Induced Obesity and Insulin Resistance.
Journal: Diabetes
Published: January 08, 2016
Last Updated: 09/26/2026